| ★ | Mitraa-T1D: AI-Driven Converastional Tool Improves T1D Diabetes Distress, Self-Care Behaviors | | 9 | Estados Unidos | |
| 13 | ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD | | 60.1K | Estados Unidos | 62 |
| 18 | Is Continuous Ketone Monitoring Future of Diabetes Care? | | 270 | Estados Unidos | 61 |
| 12 | GP-SOD Plus Targeted Phototherapy Improves Vitiligo Repigmentation | | 249 | Estados Unidos | 62 |
| 19 | What Comes Next for PORT-77 as It Heads Toward Phase 2b/3? | | 196 | Estados Unidos | 60 |
| 7 | COMP360 Psilocybin's 26-Week Data in Treatment-Resistant Depression I Boadie Dunlop, MD | | 178 | Estados Unidos | 64 |
| 2 | GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD | | 151 | Estados Unidos | 67 |
| 14 | New Martin-Hopkins LDL-C-Estimating Equation Simplifies Implementation for Comparable Results | | 151 | Estados Unidos | 62 |
| 17 | What the Phase 3 AD109 Data Mean for Sleep Apnea, With Patrick John Strollo, MD | | 142 | Estados Unidos | 61 |
| 1 | FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD | | 123 | Estados Unidos | 68 |
| 3 | GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy | | 80 | Estados Unidos | 66 |
| 15 | Bimekizumab Data Support Case for Earlier Intervention in HS | | 78 | Estados Unidos | 62 |
| 9 | Avapritinib's 4-Year Impact on Quality of Life in ISM | Thanai Pongdee, MD | | 73 | Estados Unidos | 63 |
| 4 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 65 |
| 6 | Addressing Advances and Roadblocks in Lipid Management, With Joseph Saseen, PharmD | | 64 | Estados Unidos | 64 |
| 16 | How Well-Being in Psoriasis is Being Assessed Via WHO-5, With Ulrich Mrowietz, MD | | 56 | Estados Unidos | 61 |
| 8 | POCUS is Standard of Care in Critical Care, With Rhea Votipka, NP | | 35 | Estados Unidos | 64 |
| 5 | Addressing the Manifold Barriers in Hypertension, With Michael Miedema, MD | | 27 | Estados Unidos | 65 |
| 10 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 62 |
| 20 | Abdominal Pain and Bloating: Recognizing HAE, MCAS, and Eosinophilic GI Disorders | Brian Lacy, MD | | 20 | Estados Unidos | 60 |
| 11 | Time to Minimum Residual C-Peptide As a Predictor of Treatment Efficacy in T1D | | 16 | Estados Unidos | 62 |